Suppr超能文献

基因表达揭示了两组具有临床意义的肛管癌。

Gene expression reveals two distinct groups of anal carcinomas with clinical implications.

作者信息

Bruland O, Fluge O, Immervoll H, Balteskard L, Myklebust Mp, Skarstein A, Dahl O

机构信息

Center of Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen 5021, Norway.

出版信息

Br J Cancer. 2008 Apr 8;98(7):1264-73. doi: 10.1038/sj.bjc.6604285. Epub 2008 Mar 18.

Abstract

Human papillomavirus (HPV) is a major aetiological agent in anal carcinomas. We here present a study of global gene expression using microarray hybridisation in a collection of anal carcinoma biopsies. Quantitative PCR was used to verify expression of selected genes. All biopsies contained integrated DNA of human papillomavirus subtype 16 (HPV16) and expressed HPV16 E7 mRNA. No other subspecies of HPV were detected in these 13 biopsies as assessed by PCR amplification and DNA sequencing. Unsupervised cluster analysis, based on global mRNA expression, divided the tumour biopsies into two distinct groups. Cluster analysis based on a number of high-risk HPV and/or E2F-regulated genes reproduced this biopsy grouping, suggesting that integrated HPV16 substantially influenced global gene expression in approximately half the biopsies studied. The levels of HPV16 E7 mRNA were significantly different between the two groups, but with considerable overlap. Thus, influence on global gene expression could not be absolutely ascribed to the expression level of HPV16. To investigate whether this distinction in gene expression had prognostic impact, we studied protein expression in an independent cohort of 55 anal carcinomas not included in the microarray study of two differentially expressed candidate genes, minichromosome maintenance complex component 7 (MCM7) and cyclin-dependent kinase inhibitor 2A (CDKN2A or p16). HPV status was assessed by in situ hybridisation. There was a significant association between in situ staining for HPV E7 mRNA and immunostaining for CDKN2A (p16) and MCM7 protein. CDKN2A (p16) mRNA was found significantly differentially expressed between the two tumour groups. However, cluster analysis on genes directly regulated by CDKN2A (p16) could not reproduce this split of biopsies into two groups, suggesting that the transcriptional regulatory activity of CDKN2A in these biopsies is inhibited. Furthermore, protein expression of CDKN2A (p16) could not be associated with survival. MCM7 is directly regulated by E2F and induced by HPV, and its mRNA was found differentially expressed between the two tumour groups. High level of MCM7 protein was found to be associated with both improved relapse-free survival (RFS, P=0.02) and cancer-specific survival (CSS, P=0.03) in anal cancer patients treated with radiation with or without additional chemotherapy.

摘要

人乳头瘤病毒(HPV)是肛管癌的主要病因。我们在此展示了一项利用微阵列杂交技术对一组肛管癌活检样本进行全基因组表达研究。采用定量PCR来验证所选基因的表达。所有活检样本均含有16型人乳头瘤病毒(HPV16)的整合DNA,并表达HPV16 E7 mRNA。通过PCR扩增和DNA测序评估,在这13份活检样本中未检测到其他HPV亚型。基于全基因组mRNA表达的无监督聚类分析将肿瘤活检样本分为两个不同的组。基于多个高危HPV和/或E2F调控基因的聚类分析重现了这种活检样本分组情况,表明整合的HPV16在约一半的研究活检样本中对全基因组表达有显著影响。两组之间HPV16 E7 mRNA水平存在显著差异,但有相当程度的重叠。因此,对全基因组表达的影响不能完全归因于HPV16的表达水平。为了研究这种基因表达差异是否具有预后影响,我们在一个独立的55例肛管癌队列中研究了两种差异表达候选基因微小染色体维持复合体组分7(MCM7)和细胞周期蛋白依赖性激酶抑制剂2A(CDKN2A或p16)的蛋白表达,该队列未纳入微阵列研究。通过原位杂交评估HPV状态。HPV E7 mRNA的原位染色与CDKN2A(p16)和MCM7蛋白的免疫染色之间存在显著关联。发现CDKN2A(p16)mRNA在两个肿瘤组之间存在显著差异表达。然而,基于CDKN2A(p16)直接调控基因的聚类分析无法将活检样本重现性地分为两组,这表明CDKN2A在这些活检样本中的转录调控活性受到抑制。此外,CDKN2A(p16)的蛋白表达与生存率无关。MCM7由E2F直接调控并由HPV诱导,其mRNA在两个肿瘤组之间存在差异表达。在接受放疗或联合化疗的肛管癌患者中,高水平的MCM7蛋白与无复发生存期(RFS,P = 0.02)和癌症特异性生存期(CSS,P = 0.03)的改善均相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d711/2359638/8346ebceae37/6604285f4.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验